Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rafael HoldingsRFL +16.76%49 3-Year EBITDA Growth Rate is 46.00% as of Apr. 2026. GuruFocus rates RFL with a GF Score™ of 49/100 and a GF Value™ of $1.38 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 1,368 Real Estate companies, Rafael Holdings ranks better than 88.89% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 46.00% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was -12.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 10 years, the highest 3-Year average EBITDA Per Share Growth Rate of Rafael Holdings was 46.00% per year. The lowest was -234.70% per year. And the median was -25.80% per year.
Rafael Holdings (NYSE:RFL) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Rafael Holdings 3-Year EBITDA Growth Rate Related Terms
RFL vs STHO, CNXX, CPTP: 3-Year EBITDA Growth Rate Comparison
For the Real Estate Services subindustry, Rafael Holdings's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rafael Holdings 3-Year EBITDA Growth Rate vs Real Estate Industry
For the Real Estate industry and Real Estate sector, Rafael Holdings's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Rafael Holdings's 3-Year EBITDA Growth Rate falls into.
Rafael Holdings 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 46.00% mean?
Rafael Holdings (RFL) has a 3-Year EBITDA Growth Rate of 46.00% as of Apr. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Rafael Holdings and its competitors. According to the industry distribution chart, Rafael Holdings ranks #152 out of 1368 companies in the Real Estate industry, placing it in the top 11.1%.
Is Rafael Holdings' 3-Year EBITDA Growth Rate too high?
Rafael Holdings' current 3-Year EBITDA Growth Rate is 46.00%. The Real Estate industry median 3-Year EBITDA Growth Rate is 6.30. Rafael Holdings' value of 46.00% is 630.2% above this industry median. Based on the distribution chart, Rafael Holdings ranks #152 out of 1368 companies in the Real Estate industry, which is in the top quartile — a strong position relative to peers. Overall, Rafael Holdings has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Rafael Holdings' 3-Year EBITDA Growth Rate compare to STHO and CNXX?
According to the Real Estate industry distribution chart, Rafael Holdings ranks #152 out of 1368 companies for 3-Year EBITDA Growth Rate. This places Rafael Holdings in the top 11% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 6.30. Rafael Holdings' value of 46.00% is 630.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Real Estate company?
The median 3-Year EBITDA Growth Rate among Real Estate companies is 6.30, based on 1,368 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rafael Holdings's current 3-Year EBITDA Growth Rate of 46.00% is 630.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Rafael Holdings and its competitors. For the Real Estate industry, the median 3-Year EBITDA Growth Rate is 6.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rafael Holdings's current 3-Year EBITDA Growth Rate is 46.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rafael Holdings stock overvalued right now?
Based on GuruFocus' analysis, Rafael Holdings (RFL) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.38, compared to a current price of $2.16 — trading 56.5% above its estimated fair value. The current 3-Year EBITDA Growth Rate is 46.00% and 630.2% above the Real Estate industry median of 6.30. Rafael Holdings' overall GF Score™ is 49/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Rafael Holdings (RFL), the current 3-Year EBITDA Growth Rate is 46.00% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rafael Holdings (RFL) Overvalued in 2026?
Based on GuruFocus' analysis, Rafael Holdings stock appears to be overvalued.
The current stock price of $2.16 is trading 56.5% above its estimated GF Value™ of $1.38.
GuruFocus considers Rafael Holdings to be Significantly Overvalued.
Key valuation signals for RFL:
3-Year EBITDA Growth Rate: 46.00%
GF Value™: $1.38 vs. price of $2.16 (56.5% above fair value)
Industry Position: 630.2% above the Real Estate median (#152 of 1368)
No single metric tells the full story. See the RFL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.
49GF Score
Get the complete analysis for RFL
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RFL has been successfully added to your 
